Study S001289

Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07758231
Acronym: TAP
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 5
Start: 2026-10
Primary completion: 2027-03
Lead sponsor: University of Wisconsin, Madison
Conditions: GLP-1; Alcohol
Interventions: DRUG:Acute Ethanol Dose
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:Protocol Version 7/20/26; OTHER:Pharmacy | Pharmacy Practice; OTHER:ICTR TBCR Pilot Award

Registered primary outcomes

Maximum Ethanol Concentration (Cmax) [prior to dosing (-25 minutes), start of dosing (0 minutes), 15 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes, 240 minutes, 300 minutes, 350 minutes]
Time to Maximum Ethanol Concentration (Tmax) [prior to dosing (-25 minutes), start of dosing (0 minutes), 15 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes, 240 minutes, 300 minutes, 350 minutes]
Ethanol Elimination Rate: Blood samples [prior to dosing (-25 minutes), start of dosing (0 minutes), 15 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes, 240 minutes, 300 minutes, 350 minutes]
Ethanol Elimination Rate: Breath tests [prior to dosing (-25 minutes), 30 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes, 240 minutes, 300 minutes, 350 minutes]
Ethanol Elimination Rate: Urine samples [prior to dosing (-25 minutes), 60 minutes, 120 minutes, 180 minutes, 240 minutes, 300 minutes]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.